Sulindac selectively inhibits colon tumor cell growth by activating the cGMP/PKG pathway to suppress Wnt/β-catenin signaling

相似書籍

• A Novel Sulindac Derivative that Potently Suppresses Colon Tumor Cell Growth by Inhibiting cGMP Phosphodiesterase and β-Catenin Transcriptional Activity
  由: Whitt, Jason D., et al.
  出版: (2012)
• Sulindac sulfide selectively inhibits growth and induces apoptosis of human breast tumor cells by PDE5 inhibition, elevation of cGMP, and activation of PKG
  由: Tinsley, Heather N., et al.
  出版: (2009)
• β-catenin nuclear translocation in colorectal cancer cells is suppressed by PDE10A inhibition, cGMP elevation, and activation of PKG
  由: Lee, Kevin, et al.
  出版: (2015)
• The role of cGMP and PKG in cardioprotection
  由: Downey, James M, et al.
  出版: (2009)
• PDE5 and PDE10 inhibition activates cGMP/PKG signaling to block Wnt/β-catenin transcription, cancer cell growth, and tumor immunity
  由: Piazza, Gary A., et al.
  出版: (2020)